Navigation Links
Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine

- Article Discussing Pharmacokinetics and Dose Proportionality of Company's Once-Daily Tramadol to be Published in Biopharmaceutics Journal -

LAVAL, QC, June 29, 2007 /PRNewswire-FirstCall/ - Labopharm Inc. today announced that it will present a poster discussing the dose titration of its once-daily formulation of tramadol at the 3rd International Forum on Pain Medicine to be held June 28 to July 1, 2007 in Montreal, Canada.

The poster compares two different titration schedules for Labopharm's once-daily formulation of tramadol in three Phase III clinical trials: a six-day titration to a 300 mg dose (clinical trials MDT3-002 and MDT3-003) and a nine-day titration to a 300 mg dose (clinical trial MDT3-005). The comparison showed that percentage of adverse events and discontinuations due to adverse events was similar regardless of the titration schedule.

These results, in addition to the fact that Labopharm's once-daily tramadol formulation achieves steady state plasma levels after two days, suggest that a shorter titration schedule may be adequate for most patients. A previous study showed that most patients achieve pain control using Labopharm's once-daily tramadol at a dose of 200 mg. The data in this poster suggest that, for most patients, after starting with a dose of 100 mg for two days, the therapeutic dose of 200 mg could be achieved after two days without increased risk of side effects. If a patient requires a higher dose (300 mg), the therapeutic dose could be achieved after six days of titration (100 mg for 2 days; 200 mg for 3 days then 300 mg on the 6th day) without increased risk of side effects.

"The results of the comparison of titration periods reviewed in the poster suggest that patients may benefit from rapid titration to optimal analgesia without increased risk of side effects using our product," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm
'"/>




Page: 1 2 3

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/20/2014)... MIRAGE, Calif. , Aug. 20, 2014 The ... named Fernando Davila has been successfully treated for ... disease", by Dr, Anibal R. Gauto , Medical Director ... Center, at Eisenhower Medical Center in Rancho Mirage, ... new treatment pioneered by Dr. John Crew at ...
(Date:8/20/2014)... 20, 2014 Research and Markets ... "Global Advanced Wound Care and Closure Market (Types, ... Global Trends, Company Profiles, Demand, Insights, Analysis, Research, ... report to their offering. ... and closure market (types, applications, end user and ...
(Date:8/20/2014)... PHOENIX , Aug. 20, 2014 /PRNewswire-USNewswire/ ... next-generation sequencing and proteomic diagnostics and biomarker driven ... collaboration with TESARO, Inc.  Paradigm will use its ... from clinical trials to better predict which patients ... may lead to more successful clinical trial outcomes ...
Breaking Medicine Technology:Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
(Date:8/20/2014)... 20, 2014 Locating rates for insurance packages ... Quotes Pros website. A new source of term life insurance ... rates good for all 50 states at http://quotespros.com/life-insurance.html . ... of the new methods available for the public to find ... are supplied. The instant quotations that are available are good ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 ... the past two decades, plummeting 57 percent and saving taxpayers ... estimated 4 million fewer births occurred among teenagers as a ... Centers for Disease Control and Prevention. That "eye-opening" reduction ... Bill Albert, chief program officer of The National Campaign to ...
(Date:8/20/2014)... women underwent breast reconstruction following a mastectomy for ... included being black, having a lower education level ... of the Memorial Sloan Kettering Cancer Center, New ... and Cancer Rights Act in 1998 guaranteed insurance ... most women who undergo a mastectomy do not ...
(Date:8/20/2014)... Opinion: The time to deploy Ebola vaccines is now, ... vaccines is now, according to a commentary being published ... Medicine . The authors from Yale School of ... geographic dissemination of the current Ebola outbreak represent a ... under current efforts. Several Ebola vaccines have been developed ...
(Date:8/20/2014)... Barbara Bronson Gray HealthDay Reporter ... extremely rare, colds, flu and other minor infections might ... stroke in children, a new study suggests. Just five ... the United States, said Dr. Heather Fullerton, lead author of ... the University of California, San Francisco Benioff Children,s Hospital. "It ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Price Database Now Helps Quote Prices for Adults in 50 States Online 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:News from Annals of Internal Medicine 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3
... BLOOMINGTON, Ind. -- Findings reported today (Aug. 5) from ... prayer for another person,s healing just might help -- ... person being prayed for. Candy Gunther Brown, ... at Indiana University Bloomington, led the study of "proximal ...
... for better vaccines and ways to deliver them, a ... new approach to boosting the body,s response to vaccinations. ... molecules used in drugs that treat diabetes also stimulate ... make antibodies for protection against invading microorganisms. The ...
... , WEDNESDAY, Aug. 4 (HealthDay News) -- Low cellular levels ... aggressive breast cancers, new research suggests. Testing levels of ... doctors better predict which breast cancers will return and which ... had a hint that iron might be important in cancer ...
... Wednesday, Aug. 4, 2010 A new study by ... soon help to spare some women with breast cancer from ... Investigators found that low levels of ferroportin, the ... with the most aggressive and recurring cancers. The finding suggests ...
... Oncology (ASTRO) has released evidence-based guidelines to define ... that hypofractionated (HF) WBI is effective for many ... published in the International Journal of Radiation ... Studies have shown that WBI following breast conserving ...
... identified a new mechanism that controls the number of hematopoietic ... and immune system cells. In a report in the ... of Sciences , researchers from Massachusetts General Hospital (MGH) and ... that increases the number of these blood stem cells, an ...
Cached Medicine News:Health News:Study finds proximity could be key to success of healing prayer 2Health News:Study finds proximity could be key to success of healing prayer 3Health News:Study finds proximity could be key to success of healing prayer 4Health News:UR discovers new way to boost vaccines, seeks patent 2Health News:A New Marker to Spot Aggressive Breast Cancers? 2Health News:Iron-regulating protein is strong predictor of breast cancer prognosis, study shows 2Health News:Iron-regulating protein is strong predictor of breast cancer prognosis, study shows 3Health News:ASTRO publishes whole breast irradiation guidelines 2Health News:MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment 2
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
Stryker Endoscopy has combined a standardized pressurizing system with an advanced hand piece design that is lightweight and compact in order to streamline laparoscopic procedures....
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
... to disintegrate renal and ureteral ... technology in a compact design ... and affordable lithotripsy system. The ... of clinical results for both ...
Medicine Products: